Complex therapy of patients with postviral syndrome and chronic fatigue syndrome
After suffering a new coronavirus infection COVID-19, patients face a number of disorders, the leading of which is asthenia. The purpose of our research was to study the effectiveness and safety of the use of the new biologically active complex in the rehabilitation of patients with chronic fatigue...
Saved in:
| Main Author: | A. S. Karabaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2023-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/1061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and validation of an energy level diary for fatigue management in patients with post-COVID syndrome
by: Maryam Balke, et al.
Published: (2025-07-01) -
RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis/chronic fatigue syndrome
by: Alan Cash, et al.
Published: (2024-11-01) -
Deoxygenation Trends and Their Multivariate Association with Self-Reported Fatigue in Post-COVID Syndrome
by: Anja-Maria Ladek, et al.
Published: (2025-06-01) -
Electroencephalogram characteristics in patients with chronic fatigue syndrome
by: Wu T, et al.
Published: (2016-01-01) -
COVID-19: the place of metabolic correctors in the therapy of patients with post-COVID syndrome
by: G. A. Baryshnikova, et al.
Published: (2022-03-01)